Sort by
Refine Your Search
-
Listed
-
Employer
- University of Oxford
- KINGS COLLEGE LONDON
- King's College London
- University of Oxford;
- AALTO UNIVERSITY
- Heriot Watt University
- The University of Edinburgh;
- UNIVERSITY OF VIENNA
- University of Cambridge;
- University of Liverpool
- University of London
- ;
- Atlantic Technological University;
- City University London
- Nature Careers
- Royal Horticultural Society;
- The University of Edinburgh
- University of Cambridge
- University of Dundee;
- University of Liverpool;
- 10 more »
- « less
-
Field
-
feedstocks into high value second generation chemicals. The target molecule has varied applications across the food and flavouring, pharmaceuticals and agrichemical industries. The project will be based in
-
valuable resource for investigating novel molecular mechanisms underlying gastric cancer pathogenesis, with the goal of identifying new therapeutic targets. You will work closely with academic staff
-
microbial effectors targeted host plant processes. Crucially, the project will exclude the study of plant immunity. The successful candidate will use advanced cell biology, protein biochemistry, and molecular
-
proteins that regulate many processes, from blood coagulation to extracellular matrix (ECM) homeostasis. Most serpins are inhibitory, and use a covalent mode of inhibition to inhibit their target serine
-
coagulation to extracellular matrix (ECM) homeostasis. Most serpins are inhibitory, and use a covalent mode of inhibition to inhibit their target serine proteinases (1). We and others have suggested serpins
-
their target antigens and become activated in serious human diseases, including autoimmune disorders, infectious diseases, and cancers. We study how adaptive T cell immunity is developed and/or becomes impaired
-
to join the Antigen Discovery Group at the University of Dundee. This CRUK-funded project focuses on identifying targetable T cell antigens in early-stage mesothelioma, with the goal of developing a novel
-
plans (and ongoing review) to ensure that targets are met according to study timelines. Supervision would be provided by senior Centre staff, including Professor Cathy Creswell. About You You will have or
-
mechanisms that can lead to the development of novel therapeutic targets. The individual will report to the PI of the headache Group, Dr Philip R Holland and will be responsible for conducting their own
-
world-leading researchers from Oxford, Harvard, and other premier institutions to develop innovative gene-silencing and gene-editing technologies targeting the underlying causes of genetic heart diseases